Published online Feb 24, 2024. doi: 10.5306/wjco.v15.i2.282
Peer-review started: November 26, 2023
First decision: December 25, 2023
Revised: December 26, 2023
Accepted: January 24, 2024
Article in press: January 24, 2024
Published online: February 24, 2024
Processing time: 85 Days and 17.5 Hours
Calcifying fibrous tumors (CFTs) are rare mesenchymal lesions that can occur in various sites throughout the body, including the tubular gastrointestinal (GI) tract.
To analyze the clinical findings of 36 patients with GI tract CFTs to provide guidance for diagnosis and treatment.
This retrospective study included 36 patients diagnosed with CFTs of the GI tract. We collected demographic and clinical information and conducted regular follow-ups to assess for local recurrence.
The stomach was the most commonly involved site, accounting for 72.2% of the 36 CFTs. Endoscopic mucosal resection (n = 1, 2.8%), endoscopic submucosal dissection (n = 14, 38.9%), endoscopic full-thickness resection (n = 16, 44.4%), and submucosal tunneling endoscopic resection (n = 5, 13.9%) were used to resect calcifying fibrous tumors. Overall, 34 (94.4%) CFTs underwent complete endoscopic resections with a mean procedure time of 39.8 ± 29.8 min. The average maximum diameter of the tumors was 10.6 ± 4.3 cm. No complications, such as bleeding or perforation, occurred during an average hospital stay of 2.9 ± 1.2 d. In addition, two patients developed new growth of CFTs near the primary tumor sites, and none of the patients developed distant metastases during the follow-up period.
GI tract CFTs are rare and typically benign tumors that can be effectively managed with endoscopic procedures.
Core Tip: Calcifying fibrous tumors (CFTs) are rare and benign mesenchymal neoplasms with a low risk of recurrence and are cured by local removal. The treatment of CFTs primarily aims to relieve symptoms, such as intussusception and obstruction. Gastrointestinal calcifying fibrous tumors can be removed using endoscopic procedures.